Close Menu

Wyeth

The deal was originally between Santaris and Wyeth, but Pfizer inherited the partnership when it acquired Wyeth late in 2009.

At the San Antonio Breast Cancer Symposium being held this week, Pfizer is planning to present new clinical trial data on neratinib, an investigational pan-ErbB inhibitor in patients with HER2-positive breast cancer, as well as data on the marketed oncologic Sutent (sunitinib malate) in metastatic breast cancer.

Alnylam’s request to stay the suit, which was submitted jointly with the USPTO, asked the court to suspend the case until a ruling is made on an appeal in a separate but similar patent-term suit filed by Wyeth and Elan Pharma against the patent office.

A Santaris official also said that while the company remains committed to microRNAs as drug targets, the company isn’t likely to advance additional miRNA drugs into the clinic in the near term as it takes a measured approach to selecting future clinical candidates.

Warren Bruggeman, Thomas Herzog, Lee Potts, Corey Goodman, Gregory Webb, Stephen Sands, Maggie Dias, Santiago Galvez, Elizabeth Goodman, Claudia Hillinger, Thad Seymour, Randy Scott, John Spencer, Thomas Stevens, Jim Talton, Daniel Wahby, Stephanie Warrington, Claudia Zylberberg

The new unit will be headquartered in San Diego and led by Arthur Levin, chief development officer of Denmark-based Santaris.

Pfizer La Jolla Incubator, Chromocell, NJEDA Biotechnology Development Center, Wockhardt USA LLC, Acorda Therapeutics, Eastman Business Park, Qatar Science & Technology Park, and more…

Tech Transfer Tidbits

Premium

JumpStart and Case Tech Ventures Invest in Neuros Medical; OGI Bets on UWO Spinout Cytognomix; Forma Collaborates with Singapore's ETC; and more …

The International Brotherhood of Electrical Workers launched its Stop Biotech Looting campaign last week after learning that subcontractors have been hiring non-union workers over the past year on a half-dozen projects for Boston-area life-sci giants.

People in the News

Premium

Bruno Sobral, Michael Gilman, Kathy Gibson, Uwe Christians,Herbert Fritsche, Dan Crowther

Pages

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.